Michael Morris, Guggenheim Securities analyst, joins 'Squawk on the Street' to discuss what's at stake for Netflix, some of ...

BEST OF 2024 From Monet and Van Gogh to Tim Burton and Zanele Muholi, this has been a fantastic year for art ...

With its stunning Frank Lloyd Wright design, the Guggenheim Museum is a piece of art in itself. Inside these rounded walls, ...

First Stamford Place is the new home of Guggenheim Partners' Connecticut office. Photo courtesy of Newmark Group STAMFORD – The ...

Finally, Guggenheim cut shares of GSK from a “buy” rating to a “neutral” rating in a research note on Thursday, October 31st.

in a research report on Wednesday, October 30th. Guggenheim increased their price objective on shares of Accenture from ...

Guggenheim says AI driven increase in power demand is in its early innings. Its analyst recommends owning CEG, Vistra Corp, ...

Revisiting 2024 box office predictions highlights missed expectations for “Mufasa,” “Joker,” “Inside Out 2,” “Deadpool” and ...

America—and with the land of his expatriation, France. But a fascinating new exhibit focusses on Baldwin’s years in Turkey, ...

On Friday, Altimmune Inc (ALT) stock saw a decline, ending the day at $7.67 which represents a decrease of $-0.33 or -4.13% from the prior close of $8. The stock opened at $7.9 and touched a low of $7 ...

Crispr Therapeutics AG (CRSP) stock saw a decline, ending the day at $40.02 which represents a decrease of $-1.05 or -2.56% from the prior close of $41.07. The stock opened at $40.76 and touched a low ...